セルヘルススクリーニング市場- 世界の産業規模、シェア、動向、機会、予測、検査タイプ別、検体採取部位別、地域別、競合市場別、2020-2030年

セルヘルススクリーニングの世界市場は、2024年に33億2,000万米ドルと評価され、2030年には56億7,000万米ドルに達し、CAGR 9.33％で拡大すると予測されています。

同市場は、ライフスタイルに関連した健康リスク、世界人口の高齢化、糖尿病、肥満、がんなどの疾患の増加により、著しい成長を遂げています。バランスの取れた食事や定期的な運動を通じて健康的な生活を促進することを目的としたテロメアパフォーマンスプログラムの利用が増加していることが、市場の需要をさらに押し上げています。さらに、消費者直接検査サービスの人気の高まりや、寿命や予防ヘルスケアに対する意識の高まりも、市場拡大に寄与しています。慢性疾患や加齢に関連した疾患が、特に高齢者の間で蔓延するにつれて、セルヘルススクリーニングの需要は拡大する見通しです。また、食生活の乱れががん罹患率の上昇につながり、早期発見と個別化された健康評価の必要性がさらに高まっていることも市場を後押ししています。

市場促進要因

慢性疾患の有病率の上昇

主な市場課題

高いコストと限られたアクセシビリティ

主要市場動向

スクリーニング法における先端技術の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のセルヘルススクリーニング市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • テストタイプ別（単一テストパネル、複数テストパネル）
  • サンプル（血液、唾液、尿、その他）
  • 採取場所別（自宅、病院・診療所、診断研究所、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • テストタイプ別
  • サンプル別
  • 収集場所別
  • 地域別

第6章 北米のセルヘルススクリーニング市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のセルヘルススクリーニング市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のセルヘルススクリーニング市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のセルヘルススクリーニング市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのセルヘルススクリーニング市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のセルヘルススクリーニング市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第15章 競合情勢

• Telomere Diagnostics, Inc.
• Quest Diagnostics, Inc.
• Laboratory Corporation of America Holdings
• SpectraCell Laboratories, Inc.
• Cell Science Systems Corporation
• Immundiagnostik AG
• Repeat Diagnostics, Inc.
• OPKO Health, Inc.
• Genova Diagnostics, Inc.
• Titanovo, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Cellular Health Screening Market was valued at USD 3.32 billion in 2024 and is projected to reach USD 5.67 billion by 2030, expanding at a CAGR of 9.33%. The market is witnessing significant growth due to lifestyle-related health risks, an aging global population, and a rise in conditions such as diabetes, obesity, and cancer. The increasing use of telomere performance programs, aimed at promoting healthy living through balanced diets and regular physical activity, is further driving market demand. Additionally, the growing popularity of direct-to-consumer testing services and heightened awareness around life expectancy and preventive healthcare contribute to market expansion. As chronic diseases and age-related conditions become more prevalent, especially among the elderly, the demand for cellular health screening is poised to grow. The market is also being fueled by poor dietary habits leading to rising cancer incidence, further reinforcing the need for early detection and personalized health assessments.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global surge in chronic conditions-including diabetes, cancer, and cardiovascular diseases-is a major factor accelerating growth in the cellular health screening market. These diseases often develop without early symptoms, making timely detection essential. Cellular health screening helps identify changes at the cellular level before symptoms appear, enabling earlier interventions and more personalized treatment strategies. According to the WHO, chronic illnesses are responsible for 71% of all global deaths. In the U.S., CDC data shows that 6 in 10 adults suffer from at least one chronic disease, and 4 in 10 deal with two or more. This highlights the critical need for reliable and accessible early screening tools. In response, governments are investing in preventive healthcare innovations, such as the UK's funding of a £120 blood test for early cancer detection. As cellular health screening becomes more integrated into routine healthcare, it is expected to support better patient outcomes, reduce healthcare expenditures, and propel market growth.

Key Market Challenges

High Costs and Limited Accessibility

The high cost of cellular health screening technologies remains a major challenge to broader adoption. Procedures like telomere analysis and oxidative stress testing often require sophisticated laboratory infrastructure and trained personnel, increasing expenses for providers and patients alike. This cost burden is particularly significant in developing countries where access to healthcare services is already limited. WHO estimates indicate that over 1 billion people worldwide are unable to obtain basic health services due to financial constraints. Additionally, in many regions, these screening procedures are not covered by insurance, further limiting accessibility. The lack of affordable, scalable options and reimbursement frameworks makes it difficult for a broader population to benefit from early disease detection, underscoring the need for cost-effective innovations and inclusive health policies.

Key Market Trends

Integration of Advanced Technologies in Screening Methods

Technological advancements such as artificial intelligence (AI), machine learning, and high-throughput sequencing are playing a transformative role in cellular health screening. These innovations are improving the precision, speed, and efficiency of screening procedures, allowing for the detailed analysis of cellular and genetic data. AI-driven systems can identify early disease indicators by processing large volumes of data, while high-throughput sequencing offers deep insights into genomic profiles. Such technologies support personalized healthcare approaches, enabling treatments tailored to individual biological conditions. Government funding and industry partnerships are further supporting this technological shift. As these tools become more refined and widespread, they are expected to significantly enhance diagnostic capabilities and expand the market's reach, ultimately improving healthcare outcomes on a global scale.

Key Market Players

• Telomere Diagnostics, Inc.
• Quest Diagnostics, Inc.
• Laboratory Corporation of America Holdings
• SpectraCell Laboratories, Inc.
• Cell Science Systems Corporation
• Immundiagnostik AG
• Repeat Diagnostics, Inc.
• OPKO Health, Inc.
• Genova Diagnostics, Inc.
• Titanovo, Inc.

Report Scope:

In this report, the Global Cellular Health Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cellular Health Screening Market, By Test Type:

• Single Test Panels
• Multi Test Panels

Cellular Health Screening Market, By Sample:

• Blood
• Saliva
• Urine
• Others

Cellular Health Screening Market, By Site of Collection:

• Home
• Hospitals & Clinics
• Diagnostic Laboratories
• Others

Cellular Health Screening Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cellular Health Screening Market.

Available Customizations:

Global Cellular Health Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cellular Health Screening Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Single Test Panels, Multi Test Panels)
  • 5.2.2. By Sample (Blood, Saliva, Urine, Others)
  • 5.2.3. By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Test Type
  • 5.3.2. By Sample
  • 5.3.3. By Site of Collection
  • 5.3.4. By Region

6. North America Cellular Health Screening Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Sample
  • 6.2.3. By Site of Collection
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cellular Health Screening Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Sample
      • 6.3.1.2.3. By Site of Collection
  • 6.3.2. Canada Cellular Health Screening Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Sample
      • 6.3.2.2.3. By Site of Collection
  • 6.3.3. Mexico Cellular Health Screening Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Sample
      • 6.3.3.2.3. By Site of Collection

7. Europe Cellular Health Screening Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Sample
  • 7.2.3. By Site of Collection
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cellular Health Screening Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Sample
      • 7.3.1.2.3. By Site of Collection
  • 7.3.2. Germany Cellular Health Screening Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Sample
      • 7.3.2.2.3. By Site of Collection
  • 7.3.3. United Kingdom Cellular Health Screening Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Sample
      • 7.3.3.2.3. By Site of Collection
  • 7.3.4. Italy Cellular Health Screening Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Sample
      • 7.3.4.2.3. By Site of Collection
  • 7.3.5. Spain Cellular Health Screening Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Sample
      • 7.3.5.2.3. By Site of Collection

8. Asia-Pacific Cellular Health Screening Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Sample
  • 8.2.3. By Site of Collection
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cellular Health Screening Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Sample
      • 8.3.1.2.3. By Site of Collection
  • 8.3.2. India Cellular Health Screening Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Sample
      • 8.3.2.2.3. By Site of Collection
  • 8.3.3. Japan Cellular Health Screening Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Sample
      • 8.3.3.2.3. By Site of Collection
  • 8.3.4. South Korea Cellular Health Screening Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Sample
      • 8.3.4.2.3. By Site of Collection
  • 8.3.5. Australia Cellular Health Screening Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Sample
      • 8.3.5.2.3. By Site of Collection

9. South America Cellular Health Screening Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Sample
  • 9.2.3. By Site of Collection
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cellular Health Screening Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Sample
      • 9.3.1.2.3. By Site of Collection
  • 9.3.2. Argentina Cellular Health Screening Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Sample
      • 9.3.2.2.3. By Site of Collection
  • 9.3.3. Colombia Cellular Health Screening Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Sample
      • 9.3.3.2.3. By Site of Collection

10. Middle East and Africa Cellular Health Screening Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Sample
  • 10.2.3. By Site of Collection
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cellular Health Screening Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Sample
      • 10.3.1.2.3. By Site of Collection
  • 10.3.2. Saudi Arabia Cellular Health Screening Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Sample
      • 10.3.2.2.3. By Site of Collection
  • 10.3.3. UAE Cellular Health Screening Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Sample
      • 10.3.3.2.3. By Site of Collection

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Cellular Health Screening Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

• 15.1. Telomere Diagnostics, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Quest Diagnostics, Inc.
• 15.3. Laboratory Corporation of America Holdings
• 15.4. SpectraCell Laboratories, Inc.
• 15.5. Cell Science Systems Corporation
• 15.6. Immundiagnostik AG
• 15.7. Repeat Diagnostics, Inc.
• 15.8. OPKO Health, Inc.
• 15.9. Genova Diagnostics, Inc.
• 15.10. Titanovo, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer